Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 901.00K | 1.30M | 1.46M | 1.20M | 1.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 901.00K | 1.30M | 1.46M | 1.20M | 1.22M |
| Cost of Revenue | 709.00K | 884.00K | 833.00K | 682.00K | 686.00K |
| Gross Profit | 192.00K | 418.00K | 622.00K | 518.00K | 530.00K |
| SG&A Expenses | 1.57M | 1.57M | 2.12M | 1.74M | 2.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.28M | 2.45M | 2.96M | 2.42M | 3.34M |
| Operating Income | -1.38M | -1.15M | -1.50M | -1.22M | -2.13M |
| Income Before Tax | -1.33M | 856.00K | -4.46M | 2.60M | -4.03M |
| Income Tax Expenses | 8.00K | -- | -- | -- | 8.00K |
| Earnings from Continuing Operations | -1.34M | 856.00K | -4.46M | 2.60M | -4.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -27.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.34M | 856.00K | -4.46M | 2.60M | -4.06M |
| EBIT | -1.38M | -1.15M | -1.50M | -1.22M | -2.13M |
| EBITDA | -1.37M | -1.15M | -1.49M | -1.21M | -2.10M |
| EPS Basic | -0.97 | 0.63 | -3.26 | 1.90 | -2.98 |
| Normalized Basic EPS | -0.61 | 0.39 | -2.50 | 0.39 | -1.77 |
| EPS Diluted | -0.98 | 0.62 | -3.26 | 1.90 | -2.98 |
| Normalized Diluted EPS | -0.61 | 0.39 | -1.31 | 0.39 | -1.77 |
| Average Basic Shares Outstanding | 1.37M | 1.37M | 1.37M | 1.37M | 1.37M |
| Average Diluted Shares Outstanding | 1.37M | 1.37M | 2.60M | 1.37M | 1.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |